Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET Threshold.

Ismail R, Parbo P, Hansen KV, Schaldemose JL, Dalby RB, Tietze A, Kjeldsen PL, la Cour SH, Qvist P, Gottrup H, Eskildsen SF, Brooks DJ.

J Neuroimaging. 2019 Jul;29(4):499-505. doi: 10.1111/jon.12629. Epub 2019 May 10.

PMID:
31074062
2.

Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.

Ferguson GT, Dalby RN.

Postgrad Med. 2018 Aug;130(6):515-522. doi: 10.1080/00325481.2018.1481713. Epub 2018 Jul 4. Review.

PMID:
29972656
3.

Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study.

Eskildsen SF, Gyldensted L, Nagenthiraja K, Nielsen RB, Hansen MB, Dalby RB, Frandsen J, Rodell A, Gyldensted C, Jespersen SN, Lund TE, Mouridsen K, Brændgaard H, Østergaard L.

Neurobiol Aging. 2017 Feb;50:107-118. doi: 10.1016/j.neurobiolaging.2016.11.004. Epub 2016 Nov 19.

PMID:
27951412
5.

Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks.

Xu Z, Hsu W, von Hollen D, Viswanath A, Nikander K, Dalby R.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S44-54. doi: 10.1089/jamp.2013.1074. Epub 2013 Nov 12.

PMID:
24219816
6.

Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray.

Doughty DV, Hsu W, Dalby RN.

Drug Dev Ind Pharm. 2014 Jun;40(6):711-8. doi: 10.3109/03639045.2013.777735. Epub 2013 Apr 17.

PMID:
23594299
7.

Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging.

Dalby RB, Elfving B, Poulsen PH, Foldager L, Frandsen J, Videbech P, Rosenberg R.

Acta Psychiatr Scand. 2013 Nov;128(5):387-96. doi: 10.1111/acps.12085. Epub 2013 Jan 27.

PMID:
23350796
8.

The capillary dysfunction hypothesis of Alzheimer's disease.

Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ.

Neurobiol Aging. 2013 Apr;34(4):1018-31. doi: 10.1016/j.neurobiolaging.2012.09.011. Epub 2012 Oct 18. Review.

PMID:
23084084
9.

Correlations between Stroop task performance and white matter lesion measures in late-onset major depression.

Dalby RB, Frandsen J, Chakravarty MM, Ahdidan J, Sørensen L, Rosenberg R, Østergaard L, Videbech P.

Psychiatry Res. 2012 May 31;202(2):142-9. doi: 10.1016/j.pscychresns.2011.12.009. Epub 2012 Jun 14.

PMID:
22703621
10.

Influence of immediate dentin sealing on the shear bond strength of pressed ceramic luted to dentin with self-etch resin cement.

Dalby R, Ellakwa A, Millar B, Martin FE.

Int J Dent. 2012;2012:310702. doi: 10.1155/2012/310702. Epub 2012 Jan 12.

11.

Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.

Kundoor V, Dalby RN.

Pharm Res. 2011 Aug;28(8):1895-904. doi: 10.1007/s11095-011-0417-6. Epub 2011 Apr 16.

PMID:
21499839
12.

Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.

Dalby RN, Eicher J, Zierenberg B.

Med Devices (Auckl). 2011;4:145-55. doi: 10.2147/MDER.S7409. Epub 2011 Sep 1.

13.

Deposition, imaging, and clearance: what remains to be done?

Scheuch G, Bennett W, Borgström L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, O'Callaghan C, Taylor G, Newman S.

J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S39-57. doi: 10.1089/jamp.2010.0839. Review.

PMID:
21133799
14.

Automated actuation of nasal spray products: determination and comparison of adult and pediatric settings.

Doughty DV, Vibbert C, Kewalramani A, Bollinger ME, Dalby RN.

Drug Dev Ind Pharm. 2011 Mar;37(3):359-66. doi: 10.3109/03639045.2010.520321. Epub 2010 Oct 6.

PMID:
20923391
15.

Depression severity is correlated to the integrity of white matter fiber tracts in late-onset major depression.

Dalby RB, Frandsen J, Chakravarty MM, Ahdidan J, Sørensen L, Rosenberg R, Videbech P, Ostergaard L.

Psychiatry Res. 2010 Oct 30;184(1):38-48. doi: 10.1016/j.pscychresns.2010.06.008. Epub 2010 Sep 15.

PMID:
20832255
16.

Letter to the Editor: A rejoinder to Grool et al. (2010).

Dalby RB, Rosenberg R, Østergaard L, Videbech P.

Psychol Med. 2011 Feb;41(2):446-7. doi: 10.1017/S0033291710001522. Epub 2010 Aug 24. No abstract available.

PMID:
20735882
17.

Assessment of facial and ocular deposition of nebulized aerosol using a color-based method.

Kundoor V, Dalby RN.

Drug Dev Ind Pharm. 2010 Nov;36(11):1281-5. doi: 10.3109/03639041003753854.

PMID:
20545511
18.

Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.

Adams WP, Ahrens RC, Chen ML, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O'Connor D, Parikh N, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJ, Sharp SS, Suman JD, Weda M, Woodcock J, Yu L.

J Aerosol Med Pulm Drug Deliv. 2010 Feb;23(1):1-29. doi: 10.1089/jamp.2009.0803.

PMID:
20131983
19.

Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method.

Kundoor V, Dalby RN.

Pharm Res. 2010 Jan;27(1):30-6. doi: 10.1007/s11095-009-0002-4. Epub 2009 Nov 10.

PMID:
19902337
20.

Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression.

Dalby RB, Chakravarty MM, Ahdidan J, Sørensen L, Frandsen J, Jonsdottir KY, Tehrani E, Rosenberg R, Ostergaard L, Videbech P.

Psychol Med. 2010 Aug;40(8):1389-99. doi: 10.1017/S0033291709991656. Epub 2009 Nov 9.

PMID:
19895719
21.

Use of flexible weighted nasal spray dip tubes to improve product performance.

Doughty DV, Diao L, Hoag SW, Dalby RN.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):69-75. doi: 10.1089/jamp.2008.0727.

PMID:
19778208
22.

Phospholipid-induced in vivo particle migration to enhance pulmonary deposition.

Ganguly S, Moolchandani V, Roche JA, Shapiro PS, Somaraju S, Eddington ND, Dalby RN.

J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):343-50. doi: 10.1089/jamp.2007.0675.

PMID:
18823258
23.

Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers.

Khanna N, Dalby R, Connor A, Church A, Stern J, Frazer N.

Sex Transm Dis. 2008 Jun;35(6):577-82. doi: 10.1097/OLQ.0b013e31816766af.

PMID:
18418294
24.

Phase I/II clinical safety studies of terameprocol vaginal ointment.

Khanna N, Dalby R, Tan M, Arnold S, Stern J, Frazer N.

Gynecol Oncol. 2007 Dec;107(3):554-62. Epub 2007 Oct 1.

PMID:
17905420
25.

Respiratory Drug Delivery Europe 2007.

Byron PR, Dalby RN, Peart J.

Expert Rev Respir Med. 2007 Aug;1(1):39-41. doi: 10.1586/17476348.1.1.39. No abstract available.

PMID:
20477264
26.

The analysis and prediction of functional robustness of inhaler devices.

Nithyanandan P, Hoag SW, Dalby RN.

J Aerosol Med. 2007 Spring;20(1):19-37.

PMID:
17388750
27.
28.

Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.

Laube BL, Geller DE, Lin TC, Dalby RN, Diener-West M, Zeitlin PL.

Respir Care. 2005 Nov;50(11):1438-44.

29.
30.

A review of the development of Respimat Soft Mist Inhaler.

Dalby R, Spallek M, Voshaar T.

Int J Pharm. 2004 Sep 28;283(1-2):1-9. Review.

PMID:
15363496
31.

Drug delivery to the nasal cavity: in vitro and in vivo assessment.

Newman SP, Pitcairn GR, Dalby RN.

Crit Rev Ther Drug Carrier Syst. 2004;21(1):21-66. Review.

PMID:
15099184
32.

Inhalation therapy: technological milestones in asthma treatment.

Dalby R, Suman J.

Adv Drug Deliv Rev. 2003 Jul 18;55(7):779-91. Review.

PMID:
12842600
33.

Allergen challenge and deposition of nedocromil sodium in asthma.

Laube BL, Lin TC, Valleteau A, Dalby RN, Diemer FB, Togias AG.

J Aerosol Med. 2002 Winter;15(4):415-25.

PMID:
12581508
34.

Predicting the quality of powders for inhalation from surface energy and area.

Cline D, Dalby R.

Pharm Res. 2002 Sep;19(9):1274-7.

PMID:
12403062
36.

Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Suman JD, Laube BL, Lin TC, Brouet G, Dalby R.

Pharm Res. 2002 Jan;19(1):1-6.

PMID:
11837692
38.
39.

Inhaled ATP causes mucin release from goblet cells of intact rats.

Shin CY, Kim KC, Lee WJ, Jo MJ, Park KH, Dalby R, Ko KH.

Exp Lung Res. 2000 Jan-Feb;26(1):1-11.

PMID:
10660832
40.

Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump.

Suman JD, Laube BL, Dalby R.

Pharm Res. 1999 Oct;16(10):1648-52. No abstract available.

PMID:
10554112
41.

Evaluation of aerosol drug output from the OptiChamber and AeroChamber spacers in a model system.

Dalby RN, Somaraju S, Chavan VS, Jarvis D.

J Asthma. 1998;35(2):173-7.

PMID:
9576143
42.

The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.

Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS.

J Allergy Clin Immunol. 1998 Apr;101(4 Pt 1):475-83.

PMID:
9564800
43.

Predicting in vivo lung deposition of cromolyn sodium from in vitro estimates.

Laube BL, Jashnani R, Dalby RN.

J Aerosol Med. 1998;11 Suppl 1:S35-42. No abstract available.

PMID:
10180731
44.

Pulmonary delivery of human protein C and factor IX.

Gupta S, Moussy F, Dalby RN, Miekka SI, Bruley DF.

Adv Exp Med Biol. 1997;411:429-35. No abstract available.

PMID:
9269459
45.

Comparison of a respiratory suspension aerosolized by an air-jet and an ultrasonic nebulizer.

Tiano SL, Dalby RN.

Pharm Dev Technol. 1996 Oct;1(3):261-8.

PMID:
9552308
46.

An atypical case of atypical pneumonia.

Lawrence IG, Dalby RJ, Lad NR, Shepherd RJ.

Br J Clin Pract. 1996 Sep;50(6):346-8.

PMID:
8983327
47.

Validation of an improved Wood's rotating disk dissolution apparatus.

Jashnani RN, Byron PR, Dalby RN.

J Pharm Sci. 1993 Jun;82(6):670-1. No abstract available.

PMID:
8331547
48.

Preparation, characterization, and dissolution kinetics of two novel albuterol salts.

Jashnani RN, Dalby RN, Byron PR.

J Pharm Sci. 1993 Jun;82(6):613-6.

PMID:
8331536
49.

Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers.

Phillips EM, Byron PR, Dalby RN.

Pharm Res. 1993 Mar;10(3):454-6. No abstract available.

PMID:
8464823
50.

Excess spontaneous-emission factor in unstable-resonator lasers.

Yao G, Chen YC, Harding CM, Sherrick SM, Dalby RJ, Waters RG, Largent C.

Opt Lett. 1992 Sep 1;17(17):1207-9.

PMID:
19798135

Supplemental Content

Support Center